Dynavax Technologies Corporation (LON:0IDA)
London · Delayed Price · Currency is GBP · Price in USD 10.39
+0.49 (4.94%)
At close: Aug 11, 2025
Dynavax Technologies Market Cap
Dynavax Technologies has a market cap or net worth of 918.01 million as of August 13, 2025. Its market cap has decreased by -22.34% in one year.
Market Cap
918.01M
Enterprise Value
678.16M
Revenue
230.84M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.39
Market Cap Chart
Since February 19, 2004, Dynavax Technologies's market cap has increased from 117.61M to 918.01M, an increase of 680.54%. That is a compound annual growth rate of 10.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 918.01M | -31.54% |
| Dec 31, 2024 | 1.34B | -5.49% |
| Dec 29, 2023 | 1.42B | 25.92% |
| Dec 30, 2022 | 1.13B | -9.61% |
| Dec 31, 2021 | 1.25B | 247.10% |
| Dec 31, 2020 | 359.09M | -0.86% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 171.13B |
| GSK plc | 55.99B |
| Haleon | 31.89B |
| Smith & Nephew | 11.73B |
| ConvaTec Group | 4.68B |
| Hikma Pharmaceuticals | 3.85B |
| Oxford Nanopore Technologies | 2.07B |
| HUTCHMED (China) | 1.93B |